Comparative treatment between thalidomide and the transfer factor in severe atopic dermatitis;Tratamiento comparativo entre talidomida y factor de transferencia en dermatitis atópica severa

Revista Alergia Mexico

Volumn 48, Issue 2, 2001, Pages 56-64

  Martin Sosa V ^a   Graciela Flores, S ^a   Sergio Estrada, P ^a   Modesto Orea, Solano ^a   Gómez Vera, Javier ^a  

^a HOSPITAL REGIONAL LIC ADOLFO LÓPEZ MATEOS   (Mexico)

Author keywords

Atopic dermatitis; Factor of transfer; Thalidomide

Indexed keywords

THALIDOMIDE; TRANSFER FACTOR;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOPATHOLOGY; MALE; TREATMENT OUTCOME;

EID: 0035729579     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Atopic dermatitis
2. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood
3. Pathogenesis of atopic dermatitis
4. Diagnostic features of atopic dermatitis
5. Pathogenesis of atopic dermatitis
6. Role of antigen-induced cytokine release in atopic pruritus
7. The clinical spectrum of atopic dermatitis
8. Itching and the atopic skin
9. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
10. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients
11. Effect of stress on atopic dermatitis: Investigation in patients after the great Hanshin earthquake
12. Month of birth and prevalence of atopic dermatitis in schoolchildren: Dry skin in early infancy as a possible etiologic factor
13. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis
14. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: Signs of subset expansion and stimulation
15. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: Soluble L-selectin levels indicate disease severity
16. Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis
17. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis
18. GM-CSF inhibition of monocyte apoptosis contributes to the chronic monocyte activation in atopic dermatitis
19. IgE in asthma and atopy: Cellular and molecular connections
20. Chemokines and allergic disease
21. Lymphocyte homing and homeostasis
22. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis
23. Mechanisms of eosinophil-associated inflammation
24. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity
25. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
26. In vivo expression of cytokine receptor mRNA in atopic dermatitis
27. Association of increased CD4+ T -cell infiltration with increased IL-16 gene expression in atopic dermatitis
28. Eotaxin and monocyte chemoattractant protein (MCP)-4 mRNA expression in acute versus chronic atopic dermatitis
29. Enhanced expression of eotaxin and CCR3 in atopic dermatitis
30. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory to T cells
31. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis
32. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics
33. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
34. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family
35. Identifying genes predisposing to atopic dermatitis
36. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
37. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
38. Dendritic cells in allergy
39. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells
40. IL-4 induces the intracellular expression of the a chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells
41. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
42. Food allergy, I: Immunopathogenesis and clinical disorders
43. Prevalence of IgE-mediated food allergy among children with atopic dermatitis
44. T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis
45. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens
46. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis
47. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
48. Evidence for a disease promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis
49. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production
50. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens
51. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen
52. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism
53. Autoallergy: A pathogenetic factor in atopic dermatitis?
54. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients
55. Update on therapy of atopic dermatitis
56. He management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
57. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis, ET AC Study Group: Early treatment of the atopic child
58. Phototherapy for atopic dermatitis